Daniel Markowitz
Stock Analyst at Evercore ISI Group
(1.64)
# 3,399
Out of 5,163 analysts
30
Total ratings
26.09%
Success rate
-5.27%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $250 → $260 | $187.85 | +38.41% | 3 | Feb 27, 2026 | |
| TMDX TransMedics Group | Maintains: Outperform | $155 → $170 | $123.48 | +37.67% | 2 | Feb 25, 2026 | |
| RGEN Repligen | Maintains: Outperform | $180 → $170 | $114.20 | +48.86% | 5 | Feb 25, 2026 | |
| GH Guardant Health | Maintains: In-Line | $105 → $110 | $85.49 | +28.67% | 4 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Outperform | $370 → $340 | $219.84 | +54.66% | 2 | Feb 19, 2026 | |
| TECH Bio-Techne | Maintains: In-Line | $62 → $68 | $50.85 | +33.73% | 4 | Feb 5, 2026 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $390 → $320 | $235.46 | +35.90% | 4 | Feb 3, 2026 | |
| RMBS Rambus | Maintains: Outperform | $126 → $119 | $94.01 | +26.58% | 3 | Feb 3, 2026 | |
| DXCM DexCom | Initiates: In-Line | $68 | $64.24 | +5.85% | 1 | Nov 25, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $58.62 | +113.24% | 2 | Oct 7, 2025 |
Natera
Feb 27, 2026
Maintains: Outperform
Price Target: $250 → $260
Current: $187.85
Upside: +38.41%
TransMedics Group
Feb 25, 2026
Maintains: Outperform
Price Target: $155 → $170
Current: $123.48
Upside: +37.67%
Repligen
Feb 25, 2026
Maintains: Outperform
Price Target: $180 → $170
Current: $114.20
Upside: +48.86%
Guardant Health
Feb 20, 2026
Maintains: In-Line
Price Target: $105 → $110
Current: $85.49
Upside: +28.67%
Insulet
Feb 19, 2026
Maintains: Outperform
Price Target: $370 → $340
Current: $219.84
Upside: +54.66%
Bio-Techne
Feb 5, 2026
Maintains: In-Line
Price Target: $62 → $68
Current: $50.85
Upside: +33.73%
West Pharmaceutical Services
Feb 3, 2026
Maintains: Outperform
Price Target: $390 → $320
Current: $235.46
Upside: +35.90%
Rambus
Feb 3, 2026
Maintains: Outperform
Price Target: $126 → $119
Current: $94.01
Upside: +26.58%
DexCom
Nov 25, 2025
Initiates: In-Line
Price Target: $68
Current: $64.24
Upside: +5.85%
Inspire Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $58.62
Upside: +113.24%